Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor
Natasha Honoré, A. van der Elst, Anna Dietz, Cédric van Marcke, Raphaël Helaers, Antonella Mendola, Hajar Dahou, Étienne Marbaix, Renaud Poncin, Emanuel Seront, Sandra Schmitz, Nisha Limaye, Rachel Galot, Jean‐Pascal Machiels
Topics & Concepts
ConcordanceMedicineInternal medicineOncologyHead and neckNivolumabLiquid biopsyHead and neck squamous-cell carcinomaCirculating tumor DNAHead and neck cancerGastroenterologyCancer researchCancerImmunotherapySurgeryCancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersHead and Neck Cancer Studies